Atlas Trials

Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder

Clinical trial NCT00790868 · COMPLETED

Trial details

NCT number
NCT00790868
Sponsor
Boston University Charles River Campus
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Panic Disorder
Start date
2008-04-01
Primary completion
2014-08-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.